Albuminar Market Report 2026

Albuminar Market Overview

• The Albuminar market growth in the historic period has been driven by long standing clinical use of albumin, effectiveness in shock treatment • Market expansion is supported by increasing surgical procedures, growth in ICU admissions • Growth Driver: Rising Incidence Of Burn Injuries Driving Growth In The Albuminar Market • Market Trend: Strategic Partnerships Driving Growth And Market Expansion In The Albuminar Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Albuminar Market?

Albuminar is a human albumin solution derived from plasma, used to restore blood volume and maintain oncotic pressure. It is commonly prescribed for conditions such as hypovolemia, hypoalbuminemia, and shock. It is administered intravenously and helps stabilize fluid balance in critically ill or injured patients. The main types of albuminar formulation are human serum albumin, bovine serum albumin, and recombinant albumin. Human serum albumin (HSA) is the most abundant protein found in human blood plasma, produced by the liver, and plays a crucial role in maintaining oncotic pressure, which helps keep fluid in the bloodstream and prevents it from leaking into tissues. The indications include shock treatment, burns, hypoalbuminemia, and end users are categorized into hospitals and clinics, pharmaceutical and biotechnology companies, and research institutes.

What Is The Albuminar Market Growth Forecast?

The growth in the forecast period can be attributed to increasing surgical procedures, growth in ICU admissions, rising burn injury cases, expanding healthcare infrastructure, steady demand in emergency medicine. Major trends in the forecast period include continued use of plasma derived albumin, high demand in emergency care, stable adoption in volume expansion therapy, use in critical and surgical settings, reliance on established clinical protocols.

Global Albuminar Market Segmentation

1) By Formulation: Human Serum Albumin, Bovine Serum Albumin, Recombinant Albumin 2) By Indication: Shock Treatment, Burns, Hypoalbuminemia 3) By End User: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Research Institutes

What Are The Drivers Of The Albuminar Market?

Rising incidence of burn injuries is expected to propel the albuminar market going forward. The rising incidence of burn injuries is driven by factors such as increased exposure to household hazards, workplace accidents, and fire-related incidents. Additionally, environmental factors such as wildfires and industrial accidents, along with a growing population in urban areas, contribute to the higher rates of burn injuries. Albuminar (human albumin) is commonly used in burn injuries to help restore plasma volume, maintain blood pressure, and prevent shock, particularly during the early stages of treatment. For instance, in August 2024, according to a report by the American Burn Association, a US-based organization focused on burn-related research, rehabilitation, and prevention, there were 32,540 cases in 2023 compared to 30,135 burn cases in 2022, contributing to a total of 156,073 cases over five years. Therefore, the rising incidence of burn injuries is driving the growth of the albuminar industry. An increasing number of surgical procedures is expected to propel growth of the albuminar market going forward. The rise in chronic lifestyle diseases has driven advancements in medical technology, increasing the demand for surgical procedures. These innovations have made surgeries more effective and accessible, addressing the growing healthcare needs. Albuminar is used in surgeries to restore blood volume, maintain circulatory stability, and correct hypoalbuminemia, particularly in major trauma, cardiac, liver transplantation, and orthopedic procedures. For instance, in December 2023, according to the UK Health Security Agency, a UK-based government agency, coronary artery bypass graft surgeries increased in 2023 with 27,524 surgeries compared to previous years. Therefore, the increasing number of surgical procedures is driving the growth of the albuminar industry.

Key Players In The Global Albuminar Market

Major companies operating in the albuminar market are CSL Behring LLC

Global Albuminar Market Trends and Insights

Major companies operating in the albuminar market are focusing on strategic partnership approach to enhance technology integration and expand market reach. A strategic partnership typically refers to a collaborative relationship between two or more organizations where they combine their resources, expertise, and efforts to achieve common goals or objectives. For instance, in April 2023, Kedrion Biopharma Inc., a US-based pharmaceutical manufacturer, launched a human albumin product into the Chinese market with product approval from China’s National Institutes for Food and Drug Control (NIFDC) for BPL, a UK-based company. This collaboration strengthens Kedrion’s position as a global leader in plasma products, employing over 5,000 people worldwide and operating 73 plasma collection centers in the U.S. and 5 in the Czech Republic

Regional Insights

North America was the largest region in the Albuminar market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Albuminar Market?

The albuminar market consists of sales of Albuminar 5% and Albuminar 20%. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Albuminar Market Report 2026?

The albuminar market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the albuminar industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.